154 related articles for article (PubMed ID: 18485524)
1. Detection of tumor-specific autoantibodies in sera of patients with lung cancer.
Nagashio R; Sato Y; Jiang SX; Ryuge S; Kodera Y; Maeda T; Nakajima T
Lung Cancer; 2008 Dec; 62(3):364-73. PubMed ID: 18485524
[TBL] [Abstract][Full Text] [Related]
2. Significant high expression of cytokeratins 7, 8, 18, 19 in pulmonary large cell neuroendocrine carcinomas, compared to small cell lung carcinomas.
Nagashio R; Sato Y; Matsumoto T; Kageyama T; Satoh Y; Ryuge S; Masuda N; Jiang SX; Okayasu I
Pathol Int; 2010 Feb; 60(2):71-7. PubMed ID: 20398190
[TBL] [Abstract][Full Text] [Related]
3. Anti-HuC and -HuD autoantibodies are differential sero-diagnostic markers for small cell carcinoma from large cell neuroendocrine carcinoma of the lung.
Matsumoto T; Ryuge S; Kobayashi M; Kageyama T; Hattori M; Goshima N; Jiang SX; Saegusa M; Iyoda A; Satoh Y; Masuda N; Sato Y
Int J Oncol; 2012 Jun; 40(6):1957-62. PubMed ID: 22426972
[TBL] [Abstract][Full Text] [Related]
4. Detection of eight antibodies in cancer patients' sera against proteins derived from the adenocarcinoma A549 cell line using proteomics-based analysis.
Nakanishi T; Takeuchi T; Ueda K; Murao H; Shimizu A
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):15-20. PubMed ID: 16707281
[TBL] [Abstract][Full Text] [Related]
5. A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.
Krueger P; Nitz C; Foster R; MacDonald C; Gelber O; Lalehzadeh G; Goodson R; Winter J; Gelber C
Cancer Immunol Immunother; 2003 Jun; 52(6):367-77. PubMed ID: 12669243
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel.
Nitadori J; Ishii G; Tsuta K; Yokose T; Murata Y; Kodama T; Nagai K; Kato H; Ochiai A
Am J Clin Pathol; 2006 May; 125(5):682-92. PubMed ID: 16707368
[TBL] [Abstract][Full Text] [Related]
7. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma.
Hiroshima K; Iyoda A; Shibuya K; Haga Y; Toyozaki T; Iizasa T; Nakayama T; Fujisawa T; Ohwada H
Cancer; 2004 Mar; 100(6):1190-8. PubMed ID: 15022286
[TBL] [Abstract][Full Text] [Related]
9. [Proteome analysis of autoantibodies in sera of patients with cancer].
Ueda K
Rinsho Byori; 2005 May; 53(5):437-45. PubMed ID: 15966408
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas.
Takeuchi T; Minami Y; Iijima T; Kameya T; Asamura H; Noguchi M
Pathol Int; 2006 Aug; 56(8):434-9. PubMed ID: 16872437
[TBL] [Abstract][Full Text] [Related]
11. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines.
Banks-Schlegel SP; Gazdar AF; Harris CC
Cancer Res; 1985 Mar; 45(3):1187-97. PubMed ID: 2578876
[TBL] [Abstract][Full Text] [Related]
12. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung.
Ullmann R; Petzmann S; Sharma A; Cagle PT; Popper HH
Hum Pathol; 2001 Oct; 32(10):1059-63. PubMed ID: 11679939
[TBL] [Abstract][Full Text] [Related]
14. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain.
Zhang H; Wang Y; Chen Y; Sun S; Li N; Lv D; Liu C; Huang L; He D; Xiao X
Lung Cancer; 2007 Jul; 57(1):37-45. PubMed ID: 17418446
[TBL] [Abstract][Full Text] [Related]
16. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
17. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors.
Bazhin AV; Savchenko MS; Shifrina ON; Demoura SA; Chikina SY; Jaques G; Kogan EA; Chuchalin AG; Philippov PP
Lung Cancer; 2004 May; 44(2):193-8. PubMed ID: 15084384
[TBL] [Abstract][Full Text] [Related]
18. Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung.
Sturm N; Lantuéjoul S; Laverrière MH; Papotti M; Brichon PY; Brambilla C; Brambilla E
Hum Pathol; 2001 Sep; 32(9):918-25. PubMed ID: 11567220
[TBL] [Abstract][Full Text] [Related]
19. Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionpathy.
Budde-Steffen C; Anderson NE; Rosenblum MK; Posner JB
Cancer Res; 1988 Jan; 48(2):430-4. PubMed ID: 2825975
[TBL] [Abstract][Full Text] [Related]
20. Discovery and identification of anti-U1-A snRNP antibody in lung cancer.
Zhang L; Liu J; Zhang H; Wu S; Huang L; He D; Xiao X
Sci China C Life Sci; 2005 Dec; 48(6):641-7. PubMed ID: 16483144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
